BG50159A3 - Method for preparing derivatives of piranobenzadiasole - Google Patents

Method for preparing derivatives of piranobenzadiasole

Info

Publication number
BG50159A3
BG50159A3 BG089882A BG8988289A BG50159A3 BG 50159 A3 BG50159 A3 BG 50159A3 BG 089882 A BG089882 A BG 089882A BG 8988289 A BG8988289 A BG 8988289A BG 50159 A3 BG50159 A3 BG 50159A3
Authority
BG
Bulgaria
Prior art keywords
piranobenzadiasole
preparing derivatives
derivatives
preparing
arrhythmia
Prior art date
Application number
BG089882A
Other languages
Bulgarian (bg)
English (en)
Inventor
Kiyotomo Seto
Hiroo Matsumoto
Yoshimasa Kamikawaji
Kazuhiro Ohrai
Kyoko Nakayna
Ryozo Sakoda
Yukinori Masuda
Original Assignee
Nissan Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Industries, Ltd. filed Critical Nissan Chemical Industries, Ltd.
Publication of BG50159A3 publication Critical patent/BG50159A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG089882A 1988-02-03 1989-10-02 Method for preparing derivatives of piranobenzadiasole BG50159A3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2340988 1988-02-03
JP4845888 1988-03-01
JP7576288 1988-03-29
JP12758488 1988-05-25
PCT/JP1989/000106 WO1989007103A1 (en) 1988-02-03 1989-02-02 Pyranobenzoxadiazole derivatives

Publications (1)

Publication Number Publication Date
BG50159A3 true BG50159A3 (en) 1992-05-15

Family

ID=27457958

Family Applications (1)

Application Number Title Priority Date Filing Date
BG089882A BG50159A3 (en) 1988-02-03 1989-10-02 Method for preparing derivatives of piranobenzadiasole

Country Status (17)

Country Link
US (1) US4900752A (xx)
EP (1) EP0327127B1 (xx)
JP (1) JPH0699439B2 (xx)
KR (1) KR970009591B1 (xx)
AU (1) AU609244B2 (xx)
BG (1) BG50159A3 (xx)
BR (1) BR8905292A (xx)
CA (1) CA1331990C (xx)
DE (1) DE68900210D1 (xx)
DK (2) DK167533B1 (xx)
ES (1) ES2039292T3 (xx)
FI (1) FI90240C (xx)
GR (1) GR3002637T3 (xx)
HU (1) HU206117B (xx)
RU (1) RU2054007C1 (xx)
WO (1) WO1989007103A1 (xx)
ZA (1) ZA89860B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5097037A (en) * 1989-07-17 1992-03-17 Nissan Chemical Industries, Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
GB8924373D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
DE4010097A1 (de) * 1990-03-29 1991-10-02 Basf Ag Ungesaettigte n-benzoxodiazolopyranyllactame, ihre herstellung und verwendung
JPH04342591A (ja) * 1990-07-10 1992-11-30 Nissan Chem Ind Ltd ピラノベンゾオキサジアゾール誘導体
US5164509A (en) * 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs
EP0492391A3 (en) * 1990-12-26 1993-01-20 Nissan Chemical Industries Ltd. Hair growth stimulator
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
US5352814A (en) * 1991-08-30 1994-10-04 Nissan Chemical Industries, Ltd. Asymmetric epoxidation reaction
AU677643B2 (en) * 1993-04-02 1997-05-01 Nissan Chemical Industries Ltd. Heart failure remedy
WO2005090357A1 (en) * 2004-03-23 2005-09-29 Nissan Chemical Industries, Ltd. Tricyclic benzopyran compound as anti-arrhythmic agents
GB0615670D0 (en) * 2006-08-07 2006-09-13 Syngenta Participations Ag Chemical compounds
EP3391970B1 (en) 2009-10-06 2020-01-22 Sartorius Stedim North America Inc. Method and apparatus for manipulating particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH25238A (fr) * 1901-10-22 1903-04-30 Fredinand Rozes Jean Nouvelle chaufferette
FR1406106A (fr) * 1963-04-10 1965-07-16 Daiichi Seiyaku Co Procédé de production de composés stéroïdes du [2, 3-c]-furazane
JPS5912738Y2 (ja) * 1979-04-20 1984-04-17 オリンパス光学工業株式会社 電源接続装置
EP0028064B1 (en) * 1979-09-28 1983-07-20 Beecham Group Plc Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them
DE3064285D1 (en) * 1979-09-28 1983-08-25 Beecham Group Plc Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them
EP0033612B1 (en) * 1980-02-02 1984-04-11 Beecham Group Plc Pyrano derivatives, a process for their preparation and antihypertensive compositions containing them
ZM7682A1 (en) * 1981-09-25 1983-05-23 Beecham Group Plc Active compounds

Also Published As

Publication number Publication date
DE68900210D1 (de) 1991-09-26
HU891051D0 (en) 1990-03-28
FI90240B (fi) 1993-09-30
AU609244B2 (en) 1991-04-26
DK167533B1 (da) 1993-11-15
JPH0249788A (ja) 1990-02-20
US4900752A (en) 1990-02-13
DK1693D0 (da) 1993-01-07
EP0327127B1 (en) 1991-08-21
DK1693A (da) 1993-01-07
DK169924B1 (da) 1995-04-03
HUT56373A (en) 1991-08-28
JPH0699439B2 (ja) 1994-12-07
AU2963389A (en) 1989-08-03
HU206117B (en) 1992-08-28
WO1989007103A1 (en) 1989-08-10
FI894520A (fi) 1989-09-25
GR3002637T3 (en) 1993-01-25
KR970009591B1 (ko) 1997-06-14
ES2039292T3 (es) 1993-09-16
CA1331990C (en) 1994-09-13
KR900700487A (ko) 1990-08-13
FI894520A0 (fi) 1989-09-25
ZA89860B (en) 1989-10-25
FI90240C (fi) 1994-01-10
DK486089D0 (da) 1989-10-03
RU2054007C1 (ru) 1996-02-10
DK486089A (da) 1989-12-01
EP0327127A1 (en) 1989-08-09
BR8905292A (pt) 1990-08-21

Similar Documents

Publication Publication Date Title
NO884625D0 (no) N-substituerte derivater av 1-desoksynojirimycin og 1-desoksymannojirimycin, fremgangsmaate for deres fremstilling og deres anvendelse i legemiddel.
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
BG50159A3 (en) Method for preparing derivatives of piranobenzadiasole
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
DE3684755D1 (de) Behandlung von tieren mit il-2, zubereitungen dafuer und ihre herstellung.
ES2061826T3 (es) Un procedimiento de preparacion de derivados n-2,3-butadienil triaminoalcanos.
NO862534L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater og beslektede forbindelser.
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
BG44379A3 (en) Method for preparing of 9- chlor- 1, 5- benzothiazepine derivatives
NO891723L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO881884D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO893784D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktiveimidazolderivater.
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO166280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n'-disubstituerte ureaer.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
KR900700484A (ko) 1,4:3,6-디안히드로 헥시톨 잘산염의 아미노프로판올 유도체,그의 제법 및 약제로서의 그의 용도
DE3788888D1 (de) Perhydrothiazepin- und Perhydroazepinderivate, ihre Herstellung und ihre therapeutische Verwendung.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.
NO890328D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater.